Cancer Innovation Laboratory
The CCR Cancer Innovation Laboratory (CIL) is a transdisciplinary hub to explore fundamental biological concepts and mechanisms relevant to cancer. Investigators use molecular, cellular and organismal approaches to probe known cancer mechanisms, pathways and principles and to discover new ones. The CIL also serves as a venue for the development, modification and application of novel technologies in cancer research and closely interacts with technology-centered programs on the Frederick campus including structural biology, chemical biology, bioengineering, small molecule screening and transgenic animals model generation. Research in the CIL is characterized by its highly interdisciplinary nature of bringing together experts from various backgrounds, including immunologists, cell biologists, computational biologists, chemists, geneticists, virologists and cancer biologists and a high degree of innovation, creativity and risk in the questions that are being pursued.
|Position||Degree Required||Contact Name||Contact Email|
|Post-doctoral Fellow - X-ray crystallography, HIV||Ph.D. or equivalent||Kyung Leefirstname.lastname@example.org|
|Post-doctoral Fellow - Cell biology, centrosome, cell cycle||Ph.D. or equivalent||Jadranka Loncarekemail@example.com|
Learn more about CCR research advances, new discoveries and more on our news section.
Frederick CIL Flow Cytometry Core
The CIL Flow Cytometry Core at NCI-Frederick offers comprehensive support to CCR investigators for studies of cell immunophenotyping, cell sorting, cell cycle, apoptosis and cell proliferation.
Center for Cancer Research National Cancer Institute
- Building 560, Room 31-93
- Frederick, MD 20712-1201